I. Iacobucci; C.T. Storlazzi; A. Lonetti; A. Ferrari; E. Ottaviani; S. Chiaretti; M. Messina; D. Cilloni; C. Baldazzi; C. Papayannidis; F. Messa; A. Astolfi; S. Durante; A. Vitale; F. Arruga; F. Pane; P.P. Piccaluga; S. Colarossi; S. Soverini; M. Vignetti; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli, IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME, in: s2, «HAEMATOLOGICA», 2009, 94, pp. 428 - 428 (atti di: 14th Congress of European Hematology Association, Berlin, Germany, June 4-7, 2009) [atti di convegno-abstract]
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R., IKZF1 (Ikaros) Deletions in BCR-ABL1-Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report, «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27, pp. 5202 - 5207 [articolo]
Hughes T; Saglio G; Branford S; Soverini S; Kim DW; Müller MC; Martinelli G; Cortes J; Beppu L; Gottardi E; Kim D; Erben P; Shou Y; Haque A; Gallagher N; Radich J; Hochhaus A., Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27, pp. 4204 - 4210 [articolo]
Soverini S; Poerio A; Vitale A; Gnani A; Colarossi S; Castagnetti F; Palandri F; Paolini S; Papayannidis C; Amabile M; Iacobucci I; Lonetti A; Vignetti M; Mandelli F; Baccarani M; Foà R; Martinelli G., In newly diagnosed chronic phase Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia patients, imatinib-resistant BCR-ABL mutations are already detectable at low levels but do not correlate with subsequent clinical outcome – A study by the GIMEMA ALL and GIMEMA CML Working Parties., in: supplement 4, «HAEMATOLOGICA», 2009, 94(s4), pp. 94 - 94 (atti di: 42^ Congresso Nazionale SIE, Milano, 18-21 Ottobre 2009) [atti di convegno-abstract]
Potenza L; Volzone F; Riva G; Soverini S; Martinelli S; Iacobucci I; Gnani A; Barozzi P; Forghieri F; Morselli M; Zanetti E; Maccaferri M; Baccarani M; Martinelli G; Torelli G; Luppi M., Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation, «BRITISH JOURNAL OF HAEMATOLOGY», 2009, 146, pp. 227 - 230 [articolo]
Martinelli G; Soverini S; Iacobucci I; Baccarani M., Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapy., «NATURE CLINICAL PRACTICE ONCOLOGY», 2009, 6, pp. 68 - 69 [articolo]
Soverini, Simona; Gnani, Alessandra; Colarossi, Sabrina; Vitale, Antonella; Castagnetti, Fausto; Palandri, Francesca; Paolini, Stefania; Papayannidis, Cristina; Amabile, Marilina; Iacobucci, Ilaria; Poerio, Angela; Scotlandi, Katia; Lonetti, Annalisa; Mandelli, Franco; Baccarani, Michele; Foà, Robin; Martinelli, Giovanni, Low level mutations in the Bcr-Abl kinase domain may already be detected at diagnosis both in patients with Philadelphia-positive acute lymphoblastic leukemia and in patients with chronic phase chronic myeloid leukemia, in: Volume 69, Issue 9 Supplement, «CANCER RESEARCH», 2009, pp. 3871 - 3871 (atti di: AACR Annual Meeting, Denver, CO, Apr 18-22, 2009) [atti di convegno-abstract]
Martinelli G; Iacobucci I; Soverini S; Piccaluga PP; Cilloni D; Pane F., New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia., «EXPERT REVIEW OF HEMATOLOGY», 2009, 2, pp. 297 - 303 [articolo]
Martinelli G; Iacobucci I; Papayannidis C; Soverini S., New targets for Ph+ leukaemia therapy., «BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY», 2009, 22, pp. 445 - 454 [articolo]
Rosti G; Palandri F; Castagnetti F; Breccia M; Levato L; Gugliotta G; Capucci A; Cedrone M; Fava C; Intermesoli T; Cambrin GR; Stagno F; Tiribelli M; Amabile M; Luatti S; Poerio A; Soverini S; Testoni N; Martinelli G; Alimena G; Pane F; Saglio G; Baccarani M; GIMEMA CML Working Party., Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia., «BLOOD», 2009, 114, pp. 4933 - 4938 [articolo]
Merante S.; Colombo A.A.; Calatroni S.; Rocca B.; Boni M.; Bernasconi P.; Bonvini L.; Soverini S.; Alessandrino E.P., Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation., «BONE MARROW TRANSPLANTATION», 2009, 44, pp. 263 - 264 [articolo]
Palandri F; Castagnetti F; Soverini S; Poerio A; Gugliotta G; Luatti S; Amabile M; Martinelli G; Rosti G; Baccarani M., Pancreatic enzymes elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure, «HAEMATOLOGICA», 2009, 94, pp. 1758 - 1761 [articolo]
I. Iacobucci; A. Lonetti; C.T. Storlazzi; A. Ferrari; D. Cilloni;F. Messa; S. Chiaretti; C. Papayannidis; M. Messina; A. Vitale; E. Ottaviani; S. Soverini; A. Astolfi; L. Impera; F. Arruga; P.P. Piccaluga; S. Paolini; M. Baccarani; G. Saglio; F. Pane; R. Foà; G. Martinelli, PAX5 GENE IS FREQUENTLY REARRANGED IN A LARGE COHORT OF BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: ON BEHALF OF GIMEMA AL & MDS WP, in: s2, «HAEMATOLOGICA», 2009, 94, pp. 426 - 426 (atti di: 14th Congress of European Hematology Association, Berlin, Germany, June 4-7, 2009) [atti di convegno-abstract]
Iacobucci I.; Lonetti A.; Ferrari A.; Cilloni D.; Messa F.; Guadagnolo V.; Storlazzi C.T.; Chiaretti S.; Papayannidis C.; Messina M.; Vitale A.; Ottaviani E.; Soverini S.; Arruga F.; Piccaluga P.P.; Paolini S.; Saglio G.; Pane F.; Foà R.; Baccarani M.; Martinelli G., PAX5 GENE IS FREQUENTLY THE TARGET OF GENETIC ALTERATIONS IN BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS, in: S4, «HAEMATOLOGICA», 2009, 94, pp. 2 - 2 (atti di: 42° Congresso Nazionale SIE, Milano, Italy, October 18–21, 2009) [atti di convegno-abstract]
I. Iacobucci; C. Papayannidis; F. Paoloni; A. Lonetti; M. Muschen; M. Vignetti; D. Cilloni; S. Soverini; F. Messa; S. Paolini; S. Chiaretti; V. Guadagnuolo; P. Fazi; A. Vitale; G. Meloni; M. Gobbi; M. Malagola; G. Saglio; F. Pane; M. Baccarani; R. Foà; G. Martinelli, PAX5 Wild-Type without IKZF1 (Ikaros) Deletion Is Associated with Prolonged Disease-Free Survival and Low Rate of Cumulative Incidence of Relapse in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL): On Behalf of GIMEMA AL Working Party., in: Blood, «BLOOD», 2009, 114 (22), pp. 12 - 12 (atti di: 51th ASH Annual Meeting, New Orleans, LA, Dec. 5-8, 2009) [atti di convegno-abstract]
